메뉴 건너뛰기




Volumn 9, Issue 3, 2006, Pages 109-116

Prevention of diabetes mellitus - Current state;Možnosti prevence diabetes mellitus - Aktuální stav

Author keywords

Prevention diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; CAPTOPRIL; ESTROGEN; GESTAGEN; LOSARTAN; METFORMIN; NATEGLINIDE; PLACEBO; PRAVASTATIN; RAMIPRIL; ROSIGLITAZONE; TELMISARTAN; TETRAHYDROLIPSTATIN; TROGLITAZONE; VALSARTAN;

EID: 33751581358     PISSN: 12119326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (3)

References (56)
  • 1
    • 32144448938 scopus 로고    scopus 로고
    • Standards of Medical Care in Diabetes - 2006
    • American Diabetes Association
    • American Diabetes Association. Standards of Medical Care in Diabetes - 2006. Diabetes Care 2006; 29 (Supplementum): S4-S44.
    • (2006) Diabetes Care , vol.29 , Issue.SUPPL.
  • 2
    • 85009037265 scopus 로고    scopus 로고
    • Prevention of Type 1 Diabetes Mellitus
    • American Diabetes Association
    • American Diabetes Association. Prevention of Type 1 Diabetes Mellitus. Diabetes Care 2003; 26: S 140.
    • (2003) Diabetes Care , vol.26
  • 3
    • 4243612324 scopus 로고    scopus 로고
    • Veřejně zdravotnické aspekty diabetes mellitus - Epidemiologie
    • In: Anděl M. et al. Praha. Galén
    • Anděl M. Veřejně zdravotnické aspekty diabetes mellitus - Epidemiologie. In: Anděl M. et al. Diabetes mellitus a další poruchy metabolismu. První vydání. Praha. Galén, 2001; 116-117.
    • (2001) Diabetes Mellitus a Další Poruchy Metabolismu. První Vydání , pp. 116-117
    • Anděl, M.1
  • 4
    • 4243553515 scopus 로고    scopus 로고
    • Diabetes mellitus v těhotenství-Gestační diabetes mellitus
    • In: Anděl M. et al: Praha. Galén
    • Andělová K. Diabetes mellitus v těhotenství-Gestační diabetes mellitus. In: Anděl M. et al: Diabetes mellitus a další poruchy metabolismu. První vydání Praha. Galén, 2001; 72-74.
    • (2001) Diabetes Mellitus a Další Poruchy Metabolismu. První Vydání , pp. 72-74
    • Andělová, K.1
  • 5
    • 4243626515 scopus 로고
    • Těhotenství a diabetes
    • Andělová K. Těhotenství a diabetes. Amireport 1994; 4-5: 36-38.
    • (1994) Amireport , vol.4-5 , pp. 36-38
    • Andělová, K.1
  • 6
    • 11144243375 scopus 로고    scopus 로고
    • Pharmacologic Prevention or Delay of Type 2 Diabetes Mellitus
    • Anderson DC. Pharmacologic Prevention or Delay of Type 2 Diabetes Mellitus. The Annals of Pharmacotherapy 2005; 39: 102-109.
    • (2005) The Annals of Pharmacotherapy , vol.39 , pp. 102-109
    • Anderson, D.C.1
  • 7
    • 0032053701 scopus 로고    scopus 로고
    • TRIPOD (Troglitazone In the Prevention Of Diabetes): A Randomized, Placebo-Controlled Trial of Troglitazone in Women with Prior Gestational Diabetes Mellitus
    • Azen SP et al. TRIPOD (Troglitazone In the Prevention Of Diabetes): A Randomized, Placebo-Controlled Trial of Troglitazone in Women with Prior Gestational Diabetes Mellitus. Controlled Clinical Trials 1998; 19: 217-231.
    • (1998) Controlled Clinical Trials , vol.19 , pp. 217-231
    • Azen, S.P.1
  • 8
    • 0036724346 scopus 로고    scopus 로고
    • Preservation of Pancreatic Beta-cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women
    • Buchanan TA et al. Preservation of Pancreatic Beta-cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women. Diabetes 2002; 51: 2796-2803.
    • (2002) Diabetes , vol.51 , pp. 2796-2803
    • Buchanan, T.A.1
  • 9
    • 18044392567 scopus 로고    scopus 로고
    • Dětský diabetes mellitus v České republice: Stále více a čím dál dříve
    • Cinek O et al. Dětský diabetes mellitus v České republice: stále více a čím dál dříve. Časopis lékařů českých 2005; 144: 266-272.
    • (2005) Časopis Lékařů českých , vol.144 , pp. 266-272
    • Cinek, O.1
  • 11
    • 15044342214 scopus 로고    scopus 로고
    • Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus
    • Delorme S et al. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus. Current Opinion in Pharmacology 2005; 5: 184-189.
    • (2005) Current Opinion in Pharmacology , vol.5 , pp. 184-189
    • Delorme, S.1
  • 12
    • 0037806845 scopus 로고    scopus 로고
    • Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program
    • Diabetes Prevention Program Research Group
    • c) Diabetes Prevention Program Research Group: Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program. Diabetes Care 2003; 26: 36-47.
    • (2003) Diabetes Care , vol.26 , pp. 36-47
  • 13
    • 15944424370 scopus 로고    scopus 로고
    • Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention
    • Diabetes Prevention Program Research Group
    • b) Diabetes Prevention Program Research Group: Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention Program. Diabetes Care 2005; 28: 888-894.
    • (2005) Program Diabetes Care , vol.28 , pp. 888-894
  • 14
    • 15944395414 scopus 로고    scopus 로고
    • Prevention of Type Diabetes With Troglitazone in the Diabetes Prevention Program
    • Diabetes Prevention Program Research Group Diabetes Prevention Program Research Group: Reduction in the Incidence of Type 2
    • a) Diabetes Prevention Program Research Group: Prevention of Type Diabetes With Troglitazone in the Diabetes Prevention Program. Diabetes 2005; 54: 1150-1156. Diabetes Prevention Program Research Group: Reduction in the Incidence of Type 2
    • (2005) Diabetes , vol.54 , pp. 1150-1156
  • 15
    • 0037034257 scopus 로고    scopus 로고
    • Diabetes with Lifestyle Intervention or Metformin
    • Diabetes with Lifestyle Intervention or Metformin. The New England Journal of Medicine 2002; 346: 393-403.
    • (2002) The New England Journal of Medicine , vol.346 , pp. 393-403
  • 16
    • 0042035609 scopus 로고    scopus 로고
    • Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes
    • Diabetes Prevention Program Research Group
    • b) Diabetes Prevention Program Research Group: Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes, Diabetes Care 2003; 26: 2518-2523.
    • (2003) Diabetes Care , vol.26 , pp. 2518-2523
  • 17
    • 0042168646 scopus 로고    scopus 로고
    • Effects of Withdrawal From Metformin on the Development of Diabetes in the Diabetes Prevention Program
    • Diabetes Prevention Program Research Group
    • a) Diabetes Prevention Program Research Group: Effects of Withdrawal From Metformin on the Development of Diabetes in the Diabetes Prevention Program. Diabetes Care 2003; 26: 977-980.
    • (2003) Diabetes Care , vol.26 , pp. 977-980
  • 18
    • 18144391496 scopus 로고    scopus 로고
    • Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes, The Diabetes Prevention Trial-Type 1
    • Diabetes Prevention Trial - Type 1 StudyGroup
    • Diabetes Prevention Trial - Type 1 StudyGroup.: Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes, The Diabetes Prevention Trial-Type 1. Diabetes Care 2005; 28: 1068-1076.
    • (2005) Diabetes Care , vol.28 , pp. 1068-1076
  • 19
    • 0031849339 scopus 로고    scopus 로고
    • Risk and prevention of type 2 diabetes in women with gestational diabetes
    • Dornhurst A et al. Risk and prevention of type 2 diabetes in women with gestational diabetes. Diabetes Care 1998; 21 (Suppl 2): B43-B49.
    • (1998) Diabetes Care , vol.21 , Issue.SUPPL. 2
    • Dornhurst, A.1
  • 20
    • 1642277657 scopus 로고    scopus 로고
    • European Nicotinamide Diabetes Intervention Trial (ENDIT): A randomised controlled trial of intervention before the onset of type 1 diabetes
    • European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.The Lancet 2004; 363: 925-931.
    • (2004) The Lancet , vol.363 , pp. 925-931
  • 21
    • 2142699544 scopus 로고    scopus 로고
    • Acarbose Slows Progression of Intima. Media Thickness of the Carotid Arteries in Subjects With Impaired Glucose Tolerance
    • Hanefeld M et al. Acarbose Slows Progression of Intima. Media Thickness of the Carotid Arteries in Subjects With Impaired Glucose Tolerance. Stroke 2004; 35: 1073.
    • (2004) Stroke , vol.35 , pp. 1073
    • Hanefeld, M.1
  • 22
    • 33751556971 scopus 로고    scopus 로고
    • Endokanabinoidní systém - Nový léčebný cíl u multirizikových nemocných
    • Hradec J. Endokanabinoidní systém - nový léčebný cíl u multirizikových nemocných. Remedia 2005; 15 (2): 163-168.
    • (2005) Remedia , vol.15 , Issue.2 , pp. 163-168
    • Hradec, J.1
  • 23
    • 0037097039 scopus 로고    scopus 로고
    • Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial
    • Chiasson JL et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. The Lancet 2002; 359: 2072-2077.
    • (2002) The Lancet , vol.359 , pp. 2072-2077
    • Chiasson, J.L.1
  • 24
    • 0038455703 scopus 로고    scopus 로고
    • Acarbose Treatment and The Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance. The STOP-NIDDM Trial
    • Chiasson, JL et al. Acarbose Treatment and The Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance, The STOP-NIDDM Trial JAMA 2003; 290: 486-494.
    • (2003) JAMA , vol.290 , pp. 486-494
    • Chiasson, J.L.1
  • 25
    • 9444228813 scopus 로고    scopus 로고
    • Prevention of Type 2 Diabetes, Insulin Resistance and Beta-Cell Function
    • Chiasson JL et al. Prevention of Type 2 Diabetes, Insulin Resistance and Beta-Cell Function. Diabetes 2004; 53 (Suppl 3): S34-S38.
    • (2004) Diabetes , vol.53 , Issue.SUPPL. 3
    • Chiasson, J.L.1
  • 26
    • 2642523779 scopus 로고    scopus 로고
    • Imunopatogeneze diabetes mellitus I. typu
    • Krejsek J et al. Imunopatogeneze diabetes mellitus I. typu. Vnitřní lékařství 2004, 50: 408-411.
    • (2004) Vnitřní Lékařství , vol.50 , pp. 408-411
    • Krejsek, J.1
  • 27
    • 1842526047 scopus 로고    scopus 로고
    • Můžeme zabránit manifestaci diabetu 2. typu?
    • Kvapil M. Můžeme zabránit manifestaci diabetu 2. typu? Praktický lékař 2004; 84: 152-156.
    • (2004) Praktický Lékař , vol.84 , pp. 152-156
    • Kvapil, M.1
  • 28
    • 14644408836 scopus 로고    scopus 로고
    • Endokanabinoidy - Nová možnost v léčbě metabolického syndromu a odvykání kouření
    • Kvasnička T. Endokanabinoidy - nová možnost v léčbě metabolického syndromu a odvykání kouření. Časopis lékařů českých 2005; 144 (2): 81-84.
    • (2005) Časopis Lékařů českých , vol.144 , Issue.2 , pp. 81-84
    • Kvasnička, T.1
  • 29
    • 33751567879 scopus 로고    scopus 로고
    • Vliv výživy na riziko vzniku diabetes mellitus 1. typu
    • Mendlová P et al. Vliv výživy na riziko vzniku diabetes mellitus 1. typu. Interní medicína pro praxi 2004; 531-534.
    • (2004) Interní Medicína Pro Praxi , pp. 531-534
    • Mendlová, P.1
  • 30
    • 25644457634 scopus 로고    scopus 로고
    • Differences in Cardiovascular Risk Factors, Insulin Resistance, and Insulin Secretion in Individuals With Normal Glucose Tolerance and in Subjects With Impaired Glucose Regulation
    • Nóvoa FJ et al. Differences in Cardiovascular Risk Factors, Insulin Resistance, and Insulin Secretion in Individuals With Normal Glucose Tolerance and in Subjects With Impaired Glucose Regulation, Diabetes Care 2005; 28: 2388-2393.
    • (2005) Diabetes Care , vol.28 , pp. 2388-2393
    • Nóvoa, F.J.1
  • 31
    • 17144389303 scopus 로고    scopus 로고
    • The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial
    • Orchard TJ et al. The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial 2005; 142: 611-619.
    • (2005) , vol.142 , pp. 611-619
    • Orchard, T.J.1
  • 32
    • 14644418458 scopus 로고    scopus 로고
    • A Systematic Review of Drug Therapy to Delay or Prevent Type 2 Diabetes
    • Padwal R et al. A Systematic Review of Drug Therapy to Delay or Prevent Type 2 Diabetes. Diabetes Care 2005; 28: 736-744.
    • (2005) Diabetes Care , vol.28 , pp. 736-744
    • Padwal, R.1
  • 33
    • 1542615736 scopus 로고    scopus 로고
    • Intensive Lifestyle Changes or Metformin in Patients with Impaired Glucose Tolerance: Modeling the Long-term Health Economic implications of the Diabetes Prevention Program in Australia, France, Germany, Switzerland and the United Kingdom
    • Palmer AJ et al. Intensive Lifestyle Changes or Metformin in Patients with Impaired Glucose Tolerance: Modeling the Long-term Health Economic implications of the Diabetes Prevention Program in Australia, France, Germany, Switzerland and the United Kingdom. Clinical Therapeutics 2004; 26: 304-321.
    • (2004) Clinical Therapeutics , vol.26 , pp. 304-321
    • Palmer, A.J.1
  • 34
    • 33751571986 scopus 로고    scopus 로고
    • Fetální výživa - Riziko kardiovaskulárního onemocnění a aterosklerózy?
    • Palyzová D et al. Fetální výživa - riziko kardiovaskulárního onemocnění a aterosklerózy? DMEV 2005; (suppl.) 3: 39.
    • (2005) DMEV , Issue.SUPPL. 3 , pp. 39
    • Palyzová, D.1
  • 35
    • 0030935652 scopus 로고    scopus 로고
    • Effects of diet and excercise in preventing NIDDM in people with impaired glucose tolerance: The da Qing IGT Diabetes Study
    • Pan X et al. Effects of diet and excercise in preventing NIDDM in people with impaired glucose tolerance: the da Qing IGT Diabetes Study. Diabetes Care 1997; 20: 537-544.
    • (1997) Diabetes Care , vol.20 , pp. 537-544
    • Pan, X.1
  • 36
    • 0004552507 scopus 로고    scopus 로고
    • Diabetes mellitus - Klasifikace, diagnostika, screening a epidemiologie
    • Perušičová J. Diabetes mellitus - klasifikace, diagnostika, screening a epidemiologie. Zdravotnické noviny - Lékařské listy 2001; 10: 6-10.
    • (2001) Zdravotnické Noviny - Lékařské Listy , vol.10 , pp. 6-10
    • Perušičová, J.1
  • 37
    • 33751564658 scopus 로고    scopus 로고
    • Prevence a léčba diabetes mellitus 2. Typu - Úloha endokanabinoidního systému
    • Pospíšilová Yvona. Prevence a léčba diabetes mellitus 2. typu - úloha endokanabinoidního systému. DMEV 2006; 3: 122-127.
    • (2006) DMEV , vol.3 , pp. 122-127
    • Pospíšilová, Y.1
  • 38
    • 33751560215 scopus 로고    scopus 로고
    • Vliv metforminu na funkci endotelu a oxidační stres u diabetiků 2, typu
    • Prázdný, M et al. Vliv metforminu na funkci endotelu a oxidační stres u diabetiků 2, typu, DMEV 2005; (suppl.), 3: 23.
    • (2005) DMEV , vol.3 , Issue.SUPPL. , pp. 23
    • Prázdný, M.1
  • 40
    • 33751559407 scopus 로고    scopus 로고
    • Ambulantní péče o diabetiky
    • Rybka J. Ambulantní péče o diabetiky. Medicína po promoci 2005; 6: 57-62.
    • (2005) Medicína Po Promoci , vol.6 , pp. 57-62
    • Rybka, J.1
  • 41
    • 0037364022 scopus 로고    scopus 로고
    • The prevention of type 2 diabetes - Lifestyle change or pharmacotherapy? A challenge for the 21st century
    • Simpson RW et al.The prevention of type 2 diabetes - lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Research and Clinical Practise 2003; 59: 165-180.
    • (2003) Diabetes Research and Clinical Practise , vol.59 , pp. 165-180
    • Simpson, R.W.1
  • 42
    • 33751580088 scopus 로고    scopus 로고
    • Standardní péče o diabetiky - Podle doporučení České diabetologické společnosti. Dodatky
    • In: Bartoš V et al: Praha: Maxdorf
    • Standardní péče o diabetiky - podle doporučení České diabetologické společnosti. Dodatky. In: Bartoš V et al: Praktická diabetologle. Praha: Maxdorf, 1996; 362-367.
    • (1996) Praktická Diabetologle , pp. 362-367
  • 44
    • 1642430784 scopus 로고    scopus 로고
    • Nízká porodní hmotnost a pozdější riziko diabetu 2. typu a metabolického syndromu
    • b) Svačina Š. Nízká porodní hmotnost a pozdější riziko diabetu 2. typu a metabolického syndromu. Vnitřní lékařství 2003; 49: 952-955.
    • (2003) Vnitřní Lékařství , vol.49 , pp. 952-955
    • Svačina, Š.1
  • 45
    • 3142749954 scopus 로고    scopus 로고
    • Význam markerů autoimunní inzulitidy pro klasifikaci, predikci a prevenci diabetes mellitus
    • Szabó M. Význam markerů autoimunní inzulitidy pro klasifikaci, predikci a prevenci diabetes mellitus. DMEV 2004; 2: 77-82.
    • (2004) DMEV , vol.2 , pp. 77-82
    • Szabó, M.1
  • 46
    • 33751571406 scopus 로고    scopus 로고
    • Je rozvoj metabolického syndromu naprogramován již in utero?
    • Szitányi P et al. Je rozvoj metabolického syndromu naprogramován již in utero? DMEV 2005; (suppl.), 3: 41.
    • (2005) DMEV , vol.3 , Issue.SUPPL. , pp. 41
    • Szitányi, P.1
  • 47
    • 32144437686 scopus 로고    scopus 로고
    • Diabetes mellitus 2002 v České republice - Epidemiologická studie
    • Škrha J. Diabetes mellitus 2002 v České republice - epidemiologická studie. DMEV 2005; 1: 5-12.
    • (2005) DMEV , vol.1 , pp. 5-12
    • Škrha, J.1
  • 48
    • 33751561134 scopus 로고    scopus 로고
    • Význam endokanabinoidního systému v modulaci kardiometabolických rizikových faktorů
    • Šulcová A. Význam endokanabinoidního systému v modulaci kardiometabolických rizikových faktorů. Vnitřní lékařství 2006; 52(6): 167-170.
    • (2006) Vnitřní Lékařství , vol.52 , Issue.6 , pp. 167-170
    • Šulcová, A.1
  • 49
    • 1042303480 scopus 로고    scopus 로고
    • Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
    • Torgerson JS et al. Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. Diabetes Care 2004; 27: 155-161.
    • (2004) Diabetes Care , vol.27 , pp. 155-161
    • Torgerson, J.S.1
  • 50
    • 0035799806 scopus 로고    scopus 로고
    • Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impared Glucose Tolerance
    • Tuomilehto J et al. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impared Glucose Tolerance. The New England Journal of Medicine 2001; 344: 1343-1350.
    • (2001) The New England Journal of Medicine , vol.344 , pp. 1343-1350
    • Tuomilehto, J.1
  • 51
    • 0036599363 scopus 로고    scopus 로고
    • Predikce diabetes mellitus 1. typu u českých prvostupňových příbuzných diabetických pacientů
    • Vavřinec J et al. Predikce diabetes mellitus 1. typu u českých prvostupňových příbuzných diabetických pacientů. Vnitřní lékařství 2002; 48: 483-489.
    • (2002) Vnitřní Lékařství , vol.48 , pp. 483-489
    • Vavřinec, J.1
  • 52
    • 33751566523 scopus 로고    scopus 로고
    • Pracovní dny dětské diabetologie 2003
    • a) Vavřinec J. Pracovní dny dětské diabetologie 2003. DMEV 2003; 4: 221.
    • (2003) DMEV , vol.4 , pp. 221
    • Vavřinec, J.1
  • 53
    • 33751574247 scopus 로고    scopus 로고
    • Prevence DM 1 - Intervenční studie v České republice
    • b) Vavřinec J et al. Prevence DM 1 - intervenční studie v České republice. DMEV 2003; (suppl.) 1: 59.
    • (2003) DMEV , vol.1 , Issue.SUPPL. , pp. 59
    • Vavřinec, J.1
  • 54
    • 20344381262 scopus 로고    scopus 로고
    • Diabetes mellitus- etiopatogeneza a klinika ve stáří
    • Weber P. Diabetes mellitus- etiopatogeneza a klinika ve stáří. Geriatria 2003; 9: 120-126.
    • (2003) Geriatria , vol.9 , pp. 120-126
    • Weber, P.1
  • 55
    • 33751580313 scopus 로고    scopus 로고
    • Současné možnosti terapie starších diabetiků 2. typu
    • Weber P et al. Současné možnosti terapie starších diabetiků 2. typu. Geriatria 2004; 34-40.
    • (2004) Geriatria , pp. 34-40
    • Weber, P.1
  • 56
    • 0347002050 scopus 로고    scopus 로고
    • Preventing Type 2 diabetes and dysmetabolic syndrome in the real world: A realistic view
    • Zimmet P et al. Preventing Type 2 diabetes and dysmetabolic syndrome in the real world: a realistic view. Diabetic Medicine 2003; 20: 693-702.
    • (2003) Diabetic Medicine , vol.20 , pp. 693-702
    • Zimmet, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.